1. [First trimester screening for Down syndrome: five years prospective experience].
- Author
-
Weingertner AS, Trieu NT, Kohler M, Viville B, Levy G, Montaya Y, Kutnahorsky R, Tissier I, Kohler A, Tanghe M, Mager C, Benassi E, Cancelier M, Neuman M, Bouffet N, Hunsinger MC, Hornecker F, Langer B, Nisand I, and Favre R
- Subjects
- Chorionic Gonadotropin, beta Subunit, Human blood, False Positive Reactions, Female, Humans, Maternal Age, Multicenter Studies as Topic, Nuchal Translucency Measurement, Pregnancy, Pregnancy Trimester, First, Pregnancy-Associated Plasma Protein-A analysis, Prospective Studies, Down Syndrome diagnosis, Gestational Age, Prenatal Diagnosis
- Abstract
First trimester screening for Down syndrome is yet to become the first intention strategy in France. This screening program at 11-14 weeks of gestation using maternal age, fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A has already been validated for a long time by many international studies. It seems to improve detection rate and decrease false positive rates. We report here five years prospective experience., (Copyright 2010 Elsevier Masson SAS. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF